Log in
Enquire now
‌

US Patent 10117933 Antibodies against

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
10117933
Date of Patent
November 6, 2018
Patent Application Number
14648234
Date Filed
November 29, 2013
Patent Citations Received
‌
US Patent 11952597 Compositions and methods relating to a mutant
0
‌
US Patent 10982198 Compositions and methods relating to a mutant
‌
US Patent D952157 Whole blood treatment cartridge
‌
US Patent 11357821 Recombinant clostridial neurotoxins with increased duration of effect
‌
US Patent 11535652 Compositions relating to a mutant clostridium difficile toxin and methods thereof
‌
US Patent 10774117 Compositions relating to a mutant
‌
US Patent 10787652 Compositions and methods relating to a mutant clostridium difficile toxin
Patent Primary Examiner
‌
Nita M. Minnifield
Patent abstract

Compositions and methods for the treatment or prevention of Clostridium difficile infection in a subject are provided. The compositions comprise antibodies to Clostridium difficile toxin B. The methods provide for administering the antibodies to a subject in an amount effective to reduce or eliminate or prevent relapse from Clostridium difficile bacterial infection.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 10117933 Antibodies against

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.